Creo Medical Group PLC (CREO) — Tangible Net Worth Ratio
Creo Medical Group PLC (CREO) has a Tangible Net Worth Ratio of 97.4% as of December 2025. This metric is calculated by deducting intangible assets (GBX1.30 Million) from net assets (GBX50.00 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Creo Medical Group PLC (CREO) net assets for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Creo Medical Group PLC Tangible Net Worth Ratio (2007–2025)
This chart shows how Creo Medical Group PLC's Tangible Net Worth Ratio has changed across 16 annual periods from 2007 to 2025. As of December 2025, the ratio stands at 97.4%, reflecting net assets of GBX50.00 Million with intangible assets of GBX1.30 Million GBX. Also explore CREO net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Creo Medical Group PLC (2007–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Creo Medical Group PLC from 2007 to 2025, covering 16 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see CREO market cap.
| Year | Tangible NW Ratio | Net Assets (GBX) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 97.4% | GBX50.00 Million | GBX1.30 Million | GBX59.10 Million | ▼ -1.4 pp |
| 2024 | 98.8% | GBX42.40 Million | GBX500.00K | GBX65.00 Million | ▲ +10.7 pp |
| 2023 | 88.1% | GBX59.80 Million | GBX7.10 Million | GBX76.60 Million | ▲ +44.1 pp |
| 2022 | 44.0% | GBX49.40 Million | GBX27.64 Million | GBX75.34 Million | ▼ -18.8 pp |
| 2021 | 62.8% | GBX73.32 Million | GBX27.25 Million | GBX100.61 Million | ▲ +8.3 pp |
| 2020 | 54.6% | GBX62.81 Million | GBX28.53 Million | GBX92.46 Million | ▼ -44.4 pp |
| 2019 | 99.0% | GBX82.66 Million | GBX865.24K | GBX88.26 Million | ▼ -0.4 pp |
| 2018 | 99.4% | GBX47.71 Million | GBX307.81K | GBX49.75 Million | ▼ -0.5 pp |
| 2018 | 99.9% | GBX7.33 Million | GBX7.00K | GBX9.62 Million | ▼ 0.0 pp |
| 2017 | 99.9% | GBX14.65 Million | GBX10.90K | GBX16.12 Million | ▲ +0.7 pp |
| 2016 | 99.2% | GBX1.63 Million | GBX12.88K | GBX2.42 Million | ▼ -0.4 pp |
| 2016 | 99.6% | GBX3.22 Million | GBX12.88K | GBX3.75 Million | ▼ -0.4 pp |
| 2015 | 100.0% | GBX748.41K | GBX0.00 | GBX1.04 Million | ▲ +0.0 pp |
| 2014 | 100.0% | GBX1.37 Million | GBX0.00 | GBX1.62 Million | ▲ +0.0 pp |
| 2008 | 100.0% | GBX113.00K | GBX0.00 | GBX171.00K | ▲ +0.0 pp |
| 2007 | 100.0% | GBX12.00K | GBX0.00 | GBX257.00K | — |